24 May 2013
Keywords: amgen, earnings, down, outlook, still, up, biotechnology
Article | 04 August 2008
US biotechnology major Amgen has raised its full-year financial outlook, despite an 8% drop in earnings in the second quarter as, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.